SenesTech (NASDAQ:SNES) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNESFree Report) in a research report report published on Thursday morning. The firm issued a sell rating on the stock.

Separately, HC Wainwright upped their target price on SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a report on Thursday, December 12th.

Get Our Latest Research Report on SenesTech

SenesTech Trading Down 10.1 %

SNES stock opened at $1.47 on Thursday. SenesTech has a 12 month low of $1.36 and a 12 month high of $9.80. The firm’s 50-day moving average is $2.69 and its 200 day moving average is $2.73. The company has a market capitalization of $2.57 million, a PE ratio of -0.15 and a beta of -0.03. The company has a debt-to-equity ratio of 0.05, a current ratio of 6.32 and a quick ratio of 4.92.

SenesTech (NASDAQ:SNESGet Free Report) last issued its earnings results on Wednesday, March 12th. The company reported ($1.22) EPS for the quarter, topping analysts’ consensus estimates of ($1.50) by $0.28. The business had revenue of $0.50 million for the quarter, compared to analyst estimates of $0.71 million. SenesTech had a negative net margin of 403.51% and a negative return on equity of 150.33%. On average, research analysts anticipate that SenesTech will post -10.22 EPS for the current year.

About SenesTech

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Read More

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.